Table 1 Available medical records of the CLL patients analyzed
From: Evaluation of Caspase-9b and PP2Acα2 as potential biomarkers for chronic lymphocytic leukemia
Patient | Age at diagnosis | Previous treatments | White blood cells | Hemoglobin | Platelets | Matutes score | Binet score | Caspase-9b | PP2Acα2 |
|---|---|---|---|---|---|---|---|---|---|
CLL15 | 71 | NO | 100000 | 10.2 | 86 | 4 | C | 0.05 | 11.93 |
CLL13 | 56 | NO | 97000 | 11.7 | 230 | 5 | B | 0.05 | 5.73 |
CLL12 | 63 | NO | 85000 | 12.7 | 116 | 5 | B | 0.10 | 3.96 |
CLL21 | 64 | NO | 110000 | 9.8 | 95 | 5 | B | 0.13 | 3.80 |
CLL6 | 82 | NO | 28000 | 10.6 | 206 | 5 | B | 0.57 | 3.74 |
CLL19 | 60 | YES | 230000 | 12.5 | 90 | 5 | B | 0.09 | 2.26 |
CLL5 | 72 | NO | 200000 | 12.9 | 92 | 5 | A | 1.90 | 3.68 |
CLL2 | 78 | NO | 100000 | 12.3 | 223 | 4 | A | 0.55 | 2.19 |
CLL1 | 50 | NO | 130000 | 10.9 | 189 | 5 | A | 1.34 | 1.89 |
CLL20 | 68 | NO | 87000 | 10.6 | 120 | 5 | A | 0.12 | 1.87 |
CLL16 | 43 | NO | 44000 | 15.0 | 210 | 5 | A | 0.06 | 1.38 |
CLL11 | 75 | NO | 25000 | 14.2 | 186 | 4 | A | 0.14 | 1.24 |
CLL4 | 72 | NO | 27000 | 14.6 | 250 | 5 | A | 1.30 | 1.02 |
CLL3 | 68 | NO | 80000 | 13.1 | 188 | 5 | A | 0.83 | 0.82 |
CLL17 | 87 | NO | 140000 | 10.1 | 66 | 5 | A | 0.11 | 0.38 |